LONDON, July 30, 2018 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX) a global healthcare and life science company supporting medical innovation, today announces its interim results for the period ended 30 June 2018. Financial highlights £35.6m net positive...
from PR Newswire: //https://ift.tt/2NU8p5u
No comments:
Post a Comment